Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 44 | 44 | 124 | 44 | 171 |
| Gross Profit | 44 | 44 | 124 | 44 | 171 |
| Operating Expenses | 19,385 | 25,276 | 16,118 | 29,677 | 25,286 |
| Operating Income | -19,341 | -25,232 | -15,994 | -29,633 | -25,115 |
| Other Income | 77 | 489 | 58 | 949 | 2,540 |
| Pre-tax Income | -19,264 | -24,743 | -15,936 | -28,684 | -22,575 |
| Net Income Continuous | -19,264 | -24,741 | -15,936 | -28,684 | -22,575 |
| Net Income | $-19,264 | $-24,746 | $-15,936 | $-28,684 | $-22,575 |
| EPS Basic Total Ops | -0.32 | -0.41 | -0.27 | -0.51 | -0.41 |
| EPS Basic Continuous Ops | -0.32 | -0.41 | -0.27 | -0.51 | -0.41 |
| EPS Diluted Total Ops | -0.32 | -0.41 | -0.27 | -0.51 | -0.41 |
| EPS Diluted Continuous Ops | -0.32 | -0.41 | -0.27 | -0.51 | -0.41 |
| EBITDA(a) | $-18,439 | $-24,211 | $-14,976 | $-28,863 | $-24,478 |